Advances in the management of liver and biliary tumors. Issue 5 (10th September 2022)

• Record Type: Journal Article
• Authors: Jarnagin, William R.; D'Angelica, Michael I.
• Other Names: Shah Jatin P. guestEditor.; Brennan Murray F. guestEditor.
• Is Part Of: Journal of surgical oncology. Volume 126:Issue 5(2022)
• Page Start: 872
• Page End: 875
• Publication Date: 2022-09-10
• Subjects: biliary cancer -- cholangiocarcinoma -- gallbladder cancer -- hepatic colorectal metastasis -- hepatocellular carcinoma -- liver cancer; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.27039
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract: Over the past 50 years, the management of liver and biliary tumors has evolved significantly. Initially considered highly morbid and lethal, resection is now the treatment of choice for a significant proportion of patients with malignant and benign hepatobiliary disease. Improved operative/anesthetic techniques, use of parenchymal‐sparing approaches, better patient selection for surgery, effective liver‐directed therapies, and new insights into tumor biology are significant contributors to our transformed approach to hepatobiliary neoplasms.